NIAID (The National Institute of Allergy & Infectious Diseases)
NIAID is committed to working with LE&RN to support research in the field of lymphatic disease. NIAID also supports grants and contracts for filariasis research. Visit NIAID's resource center online for more information.
New funding opportunity: Department of Health and Human Services (HHS), National Institutes of Health
The purpose of this Funding Opportunity Announcement (FOA) is to support high risk/high reward research on the blood/vascular component and regulation of the neurovascular-blood unit (a.k.a., Blood-Brain Barrier; BBB) in normal and pathological states to create enhanced/modified platforms that more closely model the human BBB. Research addressing vascular, hemostatic, hematopoietic, and/or immune cell interaction across the Blood-Brain Interface is of particular interest. This initiative will serve to stimulate the development of a new field of science and re-define the neurovascular unit to also include the blood/vascular component to develop the next generation of pre-clinical human cellular model systems of the human BBB to complement research currently based on animal models.
Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) Synopsis 1
Posted Date: September 3, 2019
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): December 2, 2019, October 19, 2020
If you are not yet a LE&RN Supporting Member, join the fight today. We need all lymphatic researchers on board to ensure a better tomorrow for the 10 million Americans and the 250 million people around the world who are struggling with LE and LD.